Impedance cardiography (HYPERGRAPH) test to detect heart decompensation and replacement fibrosis in aortic stenosis
Official title: Early Feasibility Study of the Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
Run by Dermed Diagnostics, Inc. · NCT07230964 · Data updated 2026-11-12
This project will test whether a quick impedance cardiography (HYPERGRAPH) test can detect left ventricular decompensation linked to replacement fibrosis in people with aortic stenosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 6 (estimated) |
| Sponsor | Dermed Diagnostics, Inc. Industry-sponsored |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | April 30, 2026 |
| Main results expected | October 23, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT07230964 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with moderate or severe aortic stenosis who have a recent or scheduled CMR with late gadolinium enhancement, no prior myocardial infarction or cardiac amyloidosis, and intact skin at electrode sites are the ideal candidates.
✕Probably not a fit
Patients with prior myocardial infarction or cardiac amyloidosis, those with implanted devices or metal implants that interfere with ICG, pregnant or breastfeeding women, prisoners, or people without a qualifying CMR are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational, single-center study will collect impedance cardiography (ICG) HYPERGRAPH data from six adult patients with moderate or severe aortic stenosis who have recent or planned cardiac MRI with late gadolinium enhancement and no history of myocardial infarction or cardiac amyloidosis. Participants will undergo upright and supine ICG testing and those results will be compared to CMR findings for replacement fibrosis. The aim is to determine whether ICG signatures of left ventricular decompensation correlate with CMR-detected replacement fibrosis. Data are intended to be preliminary and to inform the design of larger validation studies.
Why it matters
Potential benefit: If successful, the HYPERGRAPH ICG test could offer a quick, noninvasive way to identify patients at risk for irreversible heart damage so clinicians can consider earlier intervention.
How similar studies have gone: Cardiac MRI with late gadolinium enhancement is an established method for detecting replacement fibrosis, whereas using impedance cardiography (HYPERGRAPH) to detect fibrosis-associated decompensation is a novel approach that is not yet validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Male or female at least 18 years of age. * No prior history of myocardial infarction or cardiac amyloidosis. * Recent CMR scan with late gadolinium enhancement or scheduled for CMR scan with late gadolinium enhancement. * A history of: * Moderate aortic stenosis and no replacement fibrosis OR Moderate aortic stenosis and symptoms who has replacement fibrosis OR Severe aortic stenosis with replacement fibrosis prior to aortic valve replacement. * Able to comprehend and provide informed consent in English. * Participants must have intact, healthy skin at the electrode application sites. Exclusion Criteria: * • Under 18 years of age * Pregnant or breastfeeding women * Unable to consent * Prisoners * History of myocardial infarction * History of cardiac amyloidosis * Patients with any metal or implant such as IUD, braces, metal fragments implants in the eye, pacemakers (especially Minute Ventilation pacemakers with the MV function activated) defibrillators, or any other electronic cardiac implant. * Claustrophobic or afraid or small places. * Severe obesity (BMI \> 40) that impairs accurate ICG measurement due to difficulties in electrode placement or excessive impedance. * Active skin conditions, such as rashes, open wound or significant skin sensitivity at the electrode placement sites.
Where it's running
-
Northwestern University
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Arthur P DeMarzo, MSc
- Email: ademarzo.dermed@att.net
- Phone: 1-630-668-4644
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise and nutrition support before and after TAVI for older adults with aortic stenosis
This trial tests whether a personalized exercise program plus protein and iron supplements before and after a transcatheter valve replacement can help older adults with aortic stenosis recover better than standard care.
-
Association Between Aortic Valve Area Changes and Pulmonary Congestion After TAVI
This study tests whether improvements in aortic valve opening after TAVI relate to reductions in lung congestion measured by ultrasound in adults with severe aortic stenosis.
-
Systematic 14-day ambulatory heart monitoring after TAVI
After TAVI, patients with certain heart conduction abnormalities will try 14 days of wearable ECG monitoring to see if it lowers the chances of sudden death, symptomatic heart rhythm problems, or stroke within a year compared to standard follow-up.
-
Echo-AVCS: Drawing AI-powered clues from heart scans to confirm severe aortic stenosis
This study tests an AI-based echocardiography score to help confirm severe aortic stenosis in adults who are also getting CT calcium scoring.
-
TAVI without on-site heart surgery: can selected centers do it safely?
This trial tests whether transcatheter aortic valve implantation can be done safely in certain hospitals that don’t have on-site cardiac surgery, for patients with severe aortic stenosis who are appropriately selected.
-
Willem AI for early detection of aortic stenosis from a 12‑lead ECG
This project will test whether the Willem AI can detect aortic stenosis from routine 12‑lead ECGs in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.